RayzeBio, Inc. Common Stock - Current Ratio

The Current Ratio as of June 2026 (TTM) for RayzeBio, Inc. Common Stock (RYZB) is 28.69

According to RayzeBio, Inc. Common Stock’s latest financial reports and current stock price. The company's current Current Ratio is 28.69. This represents a change of 46.54% compared to the average of 19.58 of the last 4 quarters.

RayzeBio, Inc. Common Stock (RYZB) Historical Current Ratio (quarterly & annually)

How has RYZB Current Ratio performed in the past?

The mean historical Current Ratio of RayzeBio, Inc. Common Stock over the last ten years is 53.18. The current 28.69 Current Ratio has changed 5.29% with respect to the historical average. Over the past ten years (40 quarters), RYZB's Current Ratio was at its highest in in the September 2023 quarter at 31.85. The Current Ratio was at its lowest in in the September 2022 quarter at 0.

RayzeBio, Inc. Common Stock (RYZB) Current Ratio by Quarter and Year

Discovering the peaks and valleys of RayzeBio, Inc. Common Stock Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

RayzeBio, Inc. Common Stock (RYZB) Average Current Ratio

How has RYZB Current Ratio performed in the past?

The current Current Ratio of RayzeBio, Inc. Common Stock (RYZB) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

RayzeBio, Inc. Common Stock (RYZB) Current Ratio vs. Peers

How is RYZB’s Current Ratio compared to its peers?

RayzeBio, Inc. Common Stock’s Current Ratio is greater than CymaBay Therapeutics, Inc. (10.96), greater than SpringWorks Therapeutics, Inc. (4.33), greater than Mirati Therapeutics, Inc. (6.96), greater than Opthea Limited (0.22), greater than Alpine Immune Sciences, Inc. (7.86), less than Morphic Holding, Inc. (28.94), greater than MorphoSys AG (3.08), greater than Chinook Therapeutics, Inc. (7.59), greater than Myovant Sciences Ltd. (1.95), greater than 1Life Healthcare, Inc. (2.20),

Build a custom stock screener for RayzeBio, Inc. Common Stock (RYZB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like RayzeBio, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

RayzeBio, Inc. Common Stock (RYZB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like RayzeBio, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.